Top Markets
Coin of the day
PlexBio Co., Ltd. PlexBio Co., Ltd.

PlexBio Co., Ltd.

6572
Rang in Aktien #28557
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Aktienkurs
$0.24898639
Marktkapitalisierung
$25.81M
Veränderung (1 Tag)
8.00%
Veränderung (1 Jahr)
-24.39%
Land
TW
Handel PlexBio Co., Ltd. (6572)

Kategorie

Dividendenhistorie für PlexBio Co., Ltd. (6572)
PlexBio Co., Ltd. (Aktienkürzel: 6572) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für PlexBio Co., Ltd. (6572) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
0.00%
US
26.00%
FR
0.00%
JP
173.00%
US
0.00%
CH